Despite the findings, existing data around cardiovascular risk in chronic lymphocytic leukemia (CLL) are limited, and more ...

In the final clip, James D. Chalmers, MBChB, PhD, notes that while the FDA approval of brensocatib is a milestone, questions remain on optimal patient selection, long-term benefits, and further ...

Renal denervation modestly lowers blood pressure, with durable long-term benefits, according to Deepak L. Bhatt, MD, MPH, MBA ...

Cutting-edge therapies can help move the treatment landscape forward, but basic treatment and prevention, such as smoking ...

The definition of comprehensive non-small cell lung cancer (NSCLC) testing is rapidly evolving with new biomarkers and ...

The findings are part of a new wave of research that uses artificial intelligence (AI) to hasten scientific discovery.

New insights reveal how early intervention in radiologically isolated syndrome can delay multiple sclerosis (MS) onset and ...

In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases ...

Novel 3D analysis reveals core tumor niches drive resistance through AP-1 signaling and stromal reprogramming.

Experts discuss the persistent clinical and systemic challenges in diagnosing and treating atrial fibrillation, emphasizing ...

Male and female fat deposit distribution was associated with an increased cardiovascular age-delta; however, some adiposity ...

Experts discuss the multifaceted management of atrial fibrillation, stressing the importance of addressing comorbid ...